source
- Dr Bockorny on the Rationale for Targeting CCR8 in Solid TumorsBruno B. Bockorny, MD, discusses the rationale for evaluating the anti-CCR8 antibody in a phase 1 trial in solid tumors.onclive · 2mo ago↗ source
- Answering Key Clinical Questions About Esophageal Cancer Care: With Peter Enzinger, MDPeter Enzinger, MD, answers common questions about the diagnosis and management of esophageal cancer in this clinician-focused FAQ interview.onclive · 2mo ago↗ source
- FDA Approval Insights: Brexu-Cel for Relapsed/Refractory MCL: With Luhua (Michael) Wang, MDLuhua (Michael) Wang, MD, discusses the implications of the FDA approval of brexu-cel for the treatment of adult patients with relapsed/refractory MCL.onclive · 2mo ago